36,350.00
+1,050.00
+(2.97%)
At close: January 31 at 3:30:09 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Sang Hoon Lee Ph.D. | Founder, President & CEO | -- | -- | -- |
| Mr. Jaecheon Lee M.B.A., MBA | Executive VP, MD & CFO | -- | -- | -- |
| Mr. Jung Dae Kim M.B.A. | Executive VP & COO | -- | -- | -- |
| Dr. You Weon-Kyoo PH.D. | Executive VP, Chief Scientific Officer & Head of R&D | -- | -- | -- |
| Dr. Jaeho Jung Ph.D. | Executive VP & Chief of Discovery | -- | -- | -- |
| Dr. Jong Hwa Won Ph.D. | Executive VP, Chief Translational Research Officer & Head of Early Development | -- | -- | -- |
| Dr. Eunkyung Kim M.D., Ph.D. | Head of Medical & Clinical Development | -- | -- | -- |
ABL Bio Inc.
16 Daewangpangyo-Ro 712 Beon-Gil
2nd Floor Bundang-Gu
Seongnam-si, 13488
South Korea
- Sector:
- Healthcare
- Industry: Biotechnology
Description
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
Corporate Governance
ABL Bio Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 5, 2025 at 10:59 AM UTC - February 10, 2025 at 12:00 PM UTC
ABL Bio Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
310210.KQ Voronoi, Inc.
86,100.00
+7.22%
068270.KS Celltrion, Inc.
179,700.00
-0.28%
228760.KQ Genomictree Inc.
18,210.00
-5.65%
028300.KQ HLB Co., Ltd.
80,400.00
+1.64%
141080.KQ LigaChem Biosciences Inc.
126,500.00
+3.27%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
196170.KQ ALTEOGEN Inc.
371,500.00
+2.62%
INTS Intensity Therapeutics, Inc.
2.2100
-1.78%
VCNX Vaccinex, Inc.
1.2500
-3.10%
XNCR Xencor, Inc.
18.28
-1.19%